Johnson & Johnson and Genmab…
Johnson & Johnson and Genmab both used the festive period [...]
Ultragenyx Pharmaceutical has…
Ultragenyx Pharmaceutical has reported the failure of a pair of [...]
As the biopharma wound down for…
As the biopharma wound down for the holidays, the company reported [...]
The festive period brought some…
The festive period brought some unwanted post for both Sanofi [...]
Windtree Therapeutics has not been…
Windtree Therapeutics has not been shy about its desire to [...]
William Blair has hand-picked its…
William Blair has hand-picked its top five stock recommendations for [...]
Hope Biosciences has linked its…
Hope Biosciences has linked its stem cell therapy candidate to [...]
Despite a year of trade tensions,…
Despite a year of trade tensions, national security strictures and [...]
Six people, including a former…
Six people, including a former employee of investment bank Citigroup’s [...]
Amid news of the splashy $4.8…
Amid news of the splashy $4.8 billion Amicus buy, BioMarin [...]